Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eledon Pharmaceuticals, Inc.

3.62
-0.1100-2.95%
Post-market: 3.690.0700+1.93%18:24 EDT
Volume:538.65K
Turnover:2.00M
Market Cap:216.77M
PE:-11.47
High:3.85
Open:3.85
Low:3.60
Close:3.73
Loading ...
Nov 20, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 20, 2020

Major Issues Report

8-K - Current report
Nov 16, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 09, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 14, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 06, 2020

Major Issues Report

8-K - Current report
Oct 05, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 15, 2020

Major Issues Report

8-K - Current report
Sep 04, 2020

Major Issues Report

8-K - Current report
Aug 18, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 14, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 17, 2020

Major Issues Report

8-K - Current report
May 15, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2020

Major Issues Report

8-K - Current report
May 13, 2020

Major Issues Report

8-K - Current report
Apr 23, 2020

Major Issues Report

8-K - Current report
Apr 02, 2020

Correspondence

CORRESP [Cover] - Correspondence
Mar 25, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Mar 25, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans